Overview

Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To compare the diurnal curves in patients using bimatoprost 0.03% versus travoprost 0.004% for the treatment of glaucoma or ocular hypertension.
Phase:
Phase 4
Details
Lead Sponsor:
Innovative Medical
Treatments:
Bimatoprost
Travoprost